ALESSANDRA RINALDI GAROFALO

Submitted by ghc.content on Thu 04/20/2023 - 18:47
ALESSANDRA RINALDI GAROFALO
Non-Executive Director
/sites/default/files/2024-02/Alessandra-Rinaldi-Garofalo.png

Ms. Alessandra Rinaldi Grofalo has obtained a degree in Medicine and Surgery at the University of Rome "Tor Vergata", with a thesis in Vascular Surgery. 

From 2016 to 2018 she took up intership periods at important important hospitals, such as "Bambin Gesù" Children's Hospital, Casilino Polyclinic and “Tor Vergata” Polyclinic, also in Rome. She has volunteered at Caritas, at the Private Neuropsychiatric Hospital Villa Von Siebenthal and at several nursing homes and at assisted living facilities for the elderly. 

LUCA MATRIGIANI

Submitted by ghc.content on Thu 04/20/2023 - 18:46
LUCA MATRIGIANI
Non-Executive Director
/sites/default/files/2024-02/matrigiani-300x300.jpg

After the Master's degree in "Economics and Complementary Social Security Law" in 2015, he gained significant experience in the credit and social security sectors.
Since June 2016 he has been a member of the Board of Directors of the Enasarco Foundation and of the Advisory Committees of Fondo Europa Plus – GWM SGR, Fondo Omicron – Prelios Spa, Fondo Enasarco Uno – Prelios Spa, Fondo Algebris NPL II.

GIUSEPPE GIANNASIO

Submitted by ghc.content on Thu 04/20/2023 - 18:44
GIUSEPPE GIANNASIO
Non-Executive Director
/sites/default/files/2023-05/Giuseppe%20Giannasio.jpg

Mr. Giuseppe Giannasio holds a degree in Business Administration with a specialisation in Corporate Finance at Bocconi University of Milan. 

From 1992 to 1997 he worked as finance manager in several companies of the Montedison Group. From 1997 to 2005 he worked in the San Donato Hospital Group, where he became CEO. 

From 2007 to 2016 he was CEO  of Affidea Italia and Affidea Croatia, companies belolging to a pan European healthcare group providing outpatient healthcare services, and from 2016 to 2017 he was head of the Western Europe area. 

GUIDO DALLA ROSA PRATI

Submitted by ghc.content on Thu 04/20/2023 - 18:43
GUIDO DALLA ROSA PRATI
Executive Director
/sites/default/files/2023-05/Guido%20Dalla%20Rosa%20Prati_0.jpg

Graduated from the University of Parma, he immediately gained significant experience in healthcare management, dealing with projects aimed at building hospital structures in developing countries financed by supranational bodies (United Nations, World Bank, MAE, European Community).

CLAUDIA GAROFALO

Submitted by ghc.content on Thu 04/20/2023 - 18:41
CLAUDIA GAROFALO
Executive Director
/sites/default/files/2024-02/Claudia-Garofalo.jpg

Ms. Claudia Garofalo holds a degree in Economics and Management of Companies and Health Services at the Catholic University of the Sacred Heart in Rome (Bachelor and Master's degree). 

In 2014 she worked as an analyst at the consulting firm Deloitte & Touche. 

MARIA LAURA GAROFALO

Submitted by ghc.content on Thu 04/20/2023 - 18:32
MARIA LAURA GAROFALO
Chief Executive Officer
/sites/default/files/2024-02/Maria-Laura-Garofalo.jpg

Ms. Maria Laura Garofalo has obtained a Law degree at the University “La Sapienza ” of Rome and has gained experience in several Roman law firms as a qualified lawyer. She has also been enrolled as a lawyer. 

She obtained her Master degree from the LUISS Guido Carli University of Rome in “Small and Medium-sized Business Management” and “Company Tax Law,  and followed several courses on drafting, interpreting and analyzing financial statements. 

Homepage

Garofalo Health Care is an Italian private health care company that offers a wide range of services in all areas of the hospital, territorial and social welfare sectors.

1
Garofalo Health Care

HUMANIZATION OF CARE AND EXCELLENCE OF PERFORMANCE

Garofalo Health Care

GHC - Garofalo Health Care S.p.A. is the first and only Italian private healthcare company to be listed on the Euronext STAR segment of the Italian Stock Exchange and is headquartered in Rome. Territorial and sector diversification, innovation and professionalism, modernization and humanization of care, training and scientific research are the many characteristics and strengths that give uniqueness to the Group.

More information > 

+  

HOSPITALIZATIONS PER YEAR

~  

BEDS

~  

COLLABORATORS AND EMPLOYEES

~   

HEALTH SERVICES PROVIDED PER YEAR

OUR STRUCTURES

View all +

Financial Numbers FY 2023

 

€   M

REVENUES

 

€   M

EBITDA ADJ

 

€   M

NET INCOM

 

€   M

NFP

 

€   M

INVESTMENTS

NEWS AND EVENTS

 

A ROBOTIC PLATFORM FOR KNEE ARTHROPLASTY IN USE AT RUGANI HOSPITAL

At the Rugani Hospital in Siena, knee arthroplasty operations can be supported by Rosa
Knee System, an innovative platform that allows you to collect and analyze a whole series of data before and during surgery and provide it to the orthopedic surgeon.

This robotic technology offers a notable advantage in terms of precision and reliability of the operation with immediate and concrete effects for both the surgeon and the patient: it reduces bleeding and hospital stay and recovery times are shortened compared to an ordinary operation.

Read
Clone of Clone of Over 5 million investments in Domus Nova and San Francesco in Ravenna

Clone of Clone of Over 5 million investments in Domus Nova and San Francesco in Ravenna

The investments made by the Garofalo Health Care Group at Domus Nova and Clinica San Francesco were presented last June 12th at a press conference in Ravenna, three years after the acquisition of the two facilities.
The meeting, in the presence of Maria Laura Garofalo, CEO of the GHC Group, Michele De Pascale, Mayor of Ravenna and Tiziano Carradori, General Director of ASL Romagna, was an opportunity to summarize the investments in technological improvement and efficiency which involved both Domus Nova and Clinica San Francesco, through a plan worth over 5 million euros.

Read
Over 5 million investments in Domus Nova and San Francesco in Ravenna

Over 5 million investments in Domus Nova and San Francesco in Ravenna

The investments made by the Garofalo Health Care Group at Domus Nova and Clinica San Francesco were presented last June 12th at a press conference in Ravenna, three years after the acquisition of the two facilities.
The meeting, in the presence of Maria Laura Garofalo, CEO of the GHC Group, Michele De Pascale, Mayor of Ravenna and Tiziano Carradori, General Director of ASL Romagna, was an opportunity to summarize the investments in technological improvement and efficiency which involved both Domus Nova and Clinica San Francesco, through a plan worth over 5 million euros.

Read
Subscribe to